Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 31 of 37, showing 5 Applications out of 183 total, starting on record 151, ending on 155

# Protocol No Study Title Investigator(s) & Site(s)

151.

ECCT/15/01/05   In vivo efficacies of AL and DP
    Open label randomized study evaluating the in vivo efficacies of Artemether-lumefantrine and Dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in children under five years of age in western Kenya.   
Principal Investigator(s)
1. AAron Samuels
2. Simon Kariuki
Site(s) in Kenya
Siaya District Hospital
 
View

152.

ECCT/14/10/02  
    Acronymn: CRASH-3   Short Title: Clinical Randomisation of an Antifibrinolytic in Significant Head Injury   Full Title: Tranexamic acid for the treatment of significant traumatic brain injury: an international randomised, double blind placebo controlled trial   ISRCTN15088122   ClinicalTrials.gov ID: NCT01402882    
Principal Investigator(s)
1. Kiboi Githinji Julius
2. Dullo Michael
3. Lallet Tasneem Essaji
Site(s) in Kenya
1. Kenyatta National Hospital (Nairobi City county)
2. Kitui District Hospital (Kitui county)
3. The Nairobi Hospital (Nairobi City county)
 
View

153.

ECCT/14/09/04  
    Assessment of Safety and Efficacy of Brozedex Syrup in the Treatment of Productive Cough. Phase III, Randomized, Double Blind, Placebo-Controlled, Parallel Group and Multi-Site Study Conducted In Nairobi in three sites    
Principal Investigator(s)
1. Hudson Aubrey Lodenyo
Site(s) in Kenya
1. Rhodes Clinic/Ngaira Health Centre (Nairobi City county)
2. Mbagathi District Hospital (Nairobi City county)
3. Mama Lucy Hospital (Nairobi City county)
 
View

154.

ECCT/14/09/02   LIVING STUDY-PHASE III B.
    Prospective study of Lopinavir based ART for HIVInfected childreNGlobally (LIVING study)   
Principal Investigator(s)
1. Elizabeth Maleche Obimbo
2. Elizabeth Bukusi
3. Winstone Nyandiko
4. Bienvenu Baruani Ngoy
5. Joseph Kariuki Mbuthia
6. Allan Godfrey Otieno
7. Lucy Koech
8. Neema Mturi
9. Beatrice Mutai
Site(s) in Kenya
1. University of Nairobi/ Kenyatta National Hospital (Nairobi City county)
2. AMPATH, Moi University Teaching and Referral Hospital Eldoret (Uasin Gishu county)
3. MSF Belgium Kibera Clinic (Nairobi City county)
4. Gertrude\'s Children\'s Hospital (Nairobi City county)
5. Mbagathi District Hospital (Nairobi City county)
 
View

155.

ECCT/14/09/01   Extension to study MALARIA-055 PRI (110021) for evaluation of long-term efficacy, safety and immunogenicity of GSK Biologicals’candidate malaria vaccine (SB257049) in infants and children in Africa
    An open extension to the phase III, multi-center study MALARIA-055 PRI (110021) to evaluate long-term efficacy, safety and immunogenicity of the RTS,S/AS01E candidate vaccine against malaria disease caused by Plasmodium falciparum in infants and children in Africa.   Study number: MALARIA-076 (200599)   
Principal Investigator(s)
1. Walter Otieno
Site(s) in Kenya
Kenya Medical Research Institute/Walter Reed Project
 
View